28.89

3.85% 1.07

Baxter International Inc (BAX)

Overview News Price History Option Chain Financials Why BAX Down? Discussions Forecast Stock Split Dividend History

Baxter International Inc stock is traded at $28.89, with a volume of 5.52M. It is up +3.85% in the last 24 hours and down -17.10% over the past month. Baxter International Inc offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

Previous Close:

$27.82

Open:

$27.97

24h Volume:

5.52M

Relative Volume:

1.14

Market Cap:

$14.56B

Revenue:

$17.28B

Net Income/Loss:

$108.00M

P/E Ratio:

144.45

EPS:

0.2

Net Cash Flow:

$391.00M

1W Performance:

+2.67%

1M Performance:

-17.10%

6M Performance:

-21.17%

1Y Performance:

-26.90%

1-Day Range:

$27.92

$29.10

1-Week Range:

$26.78

$29.10

52-Week Range:

$26.25

$41.18

Baxter International Inc Stock (BAX) Company Profile

Name

Baxter International Inc

Sector

Healthcare (1151)

Industry

Medical Instruments & Supplies (63)

Phone

(847) 948-2000

Address

ONE BAXTER PKWY, DEERFIELD, IL

Employee

38,000

Twitter

@baxter_intl

Next Earnings Date

2024-11-08

Latest SEC Filings

BAX's Discussions on Twitter

Compare BAX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BAX Baxter International Inc	28.89	14.56B	17.28B	108.00M	391.00M	0.20
ISRG Intuitive Surgical Inc	482.74	175.60B	8.35B	2.32B	1.30B	6.41
BDX Becton Dickinson Co	198.71	59.07B	20.64B	1.73B	2.94B	6.02
ALC Alcon Inc	92.54	44.80B	9.91B	1.02B	665.00M	2.05
RMD Resmed Inc	212.91	31.51B	4.93B	1.25B	1.38B	8.47
COO The Cooper Companies, Inc.	79.51	15.75B	3.90B	392.30M	288.10M	1.95

Baxter International Inc Stock (BAX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-26-25	Resumed	Goldman	Buy
Feb-24-25	Upgrade	Argus	Hold → Buy
Feb-20-25	Resumed	Barclays	Overweight
Jul-15-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight
May-30-24	Initiated	Goldman	Neutral
May-10-24	Downgrade	TD Cowen	Buy → Hold
May-30-23	Resumed	Morgan Stanley	Equal-Weight
Mar-29-23	Initiated	UBS	Neutral
Jan-06-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-05-23	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-03-23	Downgrade	BofA Securities	Buy → Neutral
Dec-19-22	Downgrade	JP Morgan	Overweight → Neutral
Dec-15-22	Downgrade	Deutsche Bank	Buy → Hold
Dec-12-22	Downgrade	Citigroup	Buy → Neutral
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Hold
Jun-24-22	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-04-22	Downgrade	Goldman	Neutral → Sell
Mar-02-22	Resumed	BofA Securities	Buy
Feb-18-22	Reiterated	KeyBanc Capital Markets	Overweight
Feb-18-22	Reiterated	Morgan Stanley	Overweight
Feb-18-22	Reiterated	Raymond James	Outperform
Feb-18-22	Reiterated	Stifel	Buy
Feb-18-22	Reiterated	UBS	Neutral
Feb-18-22	Reiterated	Wells Fargo	Overweight
Feb-11-22	Initiated	Goldman	Neutral
Jan-07-22	Resumed	Citigroup	Buy
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-13-21	Upgrade	Cowen	Market Perform → Outperform
Sep-03-21	Upgrade	Barclays	Equal Weight → Overweight
May-25-21	Initiated	Barclays	Equal Weight
Jan-29-21	Downgrade	Piper Sandler	Overweight → Neutral
Jan-06-21	Downgrade	UBS	Buy → Neutral
Dec-15-20	Downgrade	Goldman	Buy → Neutral
Oct-01-20	Upgrade	Citigroup	Neutral → Buy
Sep-04-20	Downgrade	Argus	Buy → Hold
Jun-24-20	Initiated	Oppenheimer	Outperform
Mar-19-20	Upgrade	Stifel	Hold → Buy
Mar-18-20	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-05-20	Initiated	Citigroup	Neutral
Feb-13-20	Initiated	Goldman	Buy
Jan-02-20	Upgrade	Evercore ISI	In-line → Outperform
Dec-17-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-26-19	Initiated	KeyBanc Capital Markets	Sector Weight
Apr-08-19	Downgrade	Evercore ISI	Outperform → In-line
Jan-02-19	Upgrade	Citigroup	Neutral → Buy
Jan-02-19	Upgrade	Morgan Stanley	Underweight → Overweight
Nov-02-18	Upgrade	Argus	Hold → Buy
Oct-16-18	Initiated	Barclays	Underweight
May-17-18	Resumed	Piper Jaffray	Overweight
Feb-06-18	Reiterated	Citigroup	Neutral
Jan-03-18	Initiated	Evercore ISI	Outperform
Jan-03-18	Upgrade	Raymond James	Mkt Perform → Outperform

View All

Baxter International Inc Stock (BAX) Latest News

05:18 AM

Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL.com

05:18 AM

Apr 19, 2025

Dodge & Cox Boosts Stock Position in Baxter International Inc. (NYSE:BAX) - MarketBeat

Apr 19, 2025

Anchor Investment Management LLC Purchases 9,043 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat

Apr 19, 2025

Jump Financial LLC Boosts Stock Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat

Apr 19, 2025

Sterling Capital Management LLC Buys 10,768 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat

Apr 19, 2025

Gabelli Funds LLC Has $9.60 Million Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat

Apr 19, 2025

Apr 18, 2025

Here's What to Expect From Baxter International’s Next Earnings Report - MSN

Apr 18, 2025

Apr 17, 2025

Infusion Pumps Market to Soar at a CAGR of ~10% by 2032, Owing to the Advancements in Technology and Increased Demand in Healthcare | DelveInsight - GlobeNewswire Inc.

Apr 17, 2025

The Latest Breaking News on Here's What to Expect From Baxter International’s Next Earnings Report - inkl

Apr 17, 2025

Here's What To Expect From Baxter International’s Next Earnings Report - Barchart.com

Apr 17, 2025

Apr 16, 2025

Baxter International Inc. (NYSE:BAX) Shares Acquired by Jaffetilchin Investment Partners LLC - MarketBeat

Apr 16, 2025

Apr 15, 2025

Baxter to Host First-Quarter 2025 Financial Results Conference C - GuruFocus

Apr 15, 2025

Baxter to Host First-Quarter 2025 Financial Results Conference Call for Investors - Business Wire

Apr 15, 2025

Latest Trends in Adhesion Barrier Market: 2024 to 2031 | Baxter - openPR.com

Apr 15, 2025

Apr 14, 2025

LSV Asset Management Has $159.96 Million Stake in Baxter International Inc. (NYSE:BAX) - MarketBeat

Apr 14, 2025

Baxter International (NYSE:BAX) Reaches New 1-Year LowShould You Sell? - MarketBeat

Apr 14, 2025

Baxter International Inc. (NYSE:BAX) Position Raised by Russell Investments Group Ltd. - MarketBeat

Apr 11, 2025

Baxter International Enters Oversold Territory (BAX) - Nasdaq

Apr 11, 2025

Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery - PharmiWeb.com

Apr 11, 2025

Baxter Launches New Room Temperature Hemopatch Sealing Hemostat - GuruFocus

Apr 11, 2025

Apr 10, 2025

Cullen Capital Management LLC Decreases Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat

Apr 10, 2025

Baxter International Inc. Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery - marketscreener.com

Apr 10, 2025

Breakthrough: Baxter's Enhanced Hemopatch Eliminates Surgery Prep Time with Room-Temperature Storage - Stock Titan

Apr 10, 2025

Geode Capital Management LLC Buys 290,279 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat

Apr 10, 2025

Apr 09, 2025

Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 09, 2025

Wound Care Market to Witness Remarkable Growth with 3M, Baxter, - openPR.com

Apr 09, 2025

Apr 08, 2025

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Baxter International Inc.(BAX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Apr 08, 2025

Artificial Kidney Market to See Revolutionary Growth | Baxter - openPR.com

Apr 08, 2025

Apr 07, 2025